SCH1

SCH1, also known as SCH-1, is a research compound that was primarily investigated as a dopamine receptor ligand. Chemically identified as 1-benzyl-4-(2,6-dimethylphenyl)piperazine, it belongs to the piperazine class of molecules. Early pharmacological studies explored its potential as a dopamine D1 receptor antagonist, a class of drugs that block the action of dopamine at the D1-like receptor family. While it served as a structural lead in the development of more selective and potent dopamine antagonists by Schering-Plough, it did not progress into advanced clinical development for specific therapeutic indications. Its primary utility remains in the field of neuroscience research for characterizing dopamine receptor binding profiles and investigating the role of dopaminergic signaling in the central nervous system.

Other names

1-benzyl-4-(2,6-dimethylphenyl)piperazine